FDA and trial operations – real-time signal sharing pilots

The FDA launched and validated pilots for real-time clinical trials (RTCTs), aiming to shorten the time required for early-phase signal review by enabling endpoint and safety data reporting as trials progress. The agency said it met with AstraZeneca and Amgen before start-up to define reporting criteria and later validated signals through its technical framework for real-time signal sharing.